Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008616417> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2008616417 abstract "Purpose. —To resolve discrepancies in previous systematic overviews and provide estimates of the effect of stress ulcer prophylaxis on gastrointestinal bleeding, pneumonia, and mortality in critically ill patients. Data Identification. —Computerized search of published and unpublished research, bibliographies, pharmaceutical and personal files, and conference abstract reports. Study Selection. —Independent review of 269 articles identified 63 relevant randomized trials for inclusion. Data Abstraction. —We made independent, duplicate assessment of the methodologic quality, population, intervention, and outcomes of each trial. Results. —The source of discrepancies between prior meta-analyses included incomplete identification of relevant studies, differential inclusion of non—English language and nonrandomized trials, different definitions of bleeding, provision of additional information through direct correspondence with authors, and different statistical methods. The current overview demonstrates that prophylaxis with histamine2-receptor antagonists decreases the incidence of overt gastrointestinal bleeding (odds ratio [OR], 0.58; 95% confidence interval [CI], 0.42 to 0.79) and clinically important bleeding (OR, 0.44; 95% CI, 0.22 to 0.88). There is a trend toward decreased overt bleeding when antacids are compared with no therapy (OR, 0.66; 95% CI, 0.37 to 1.17). Histamine2-receptor antagonists and antacids are associated with a trend toward lower clinically important bleeding rates than sucralfate is. There is a trend toward an increased risk of pneumonia associated with histamine2-receptor antagonists as compared with no prophylaxis (OR, 1.25; 95% CI, 0.78 to 2.00). Sucralfate is associated with a lower incidence of nosocomial pneumonia when compared with antacids (OR, 0.80; 95% CI, 0.56 to 1.15) and histamine2-receptor antagonists (OR, 0.77; 95% CI, 0.60 to 1.01). Sucralfate is also associated with a reduced mortality rate (OR, 0.73; 95% CI, 0.54 to 0.97) relative to antacids and to histamine2-receptor antagonists (OR, 0.83; 95% CI, 0.63 to 1.09). Conclusions. —Our results emphasize the need for registries to include all randomized trials and demonstrate the importance of explicit methodology for systematic reviews. There is strong evidence of reduced clinically important gastrointestinal bleeding with histamine2-receptor antagonists. Sucralfate may be as effective in reducing bleeding as gastric pH—altering drugs and is associated with lower rates of pneumonia and mortality. However, the data are insufficient to determine the net effect of sucralfate compared with no prophylaxis. (JAMA. 1996;275:308-314)" @default.
- W2008616417 created "2016-06-24" @default.
- W2008616417 creator A5012951861 @default.
- W2008616417 creator A5015709785 @default.
- W2008616417 creator A5017849159 @default.
- W2008616417 creator A5025705076 @default.
- W2008616417 creator A5031717153 @default.
- W2008616417 creator A5082524174 @default.
- W2008616417 creator A5084752934 @default.
- W2008616417 date "1996-12-01" @default.
- W2008616417 modified "2023-09-26" @default.
- W2008616417 title "Stress Ulcer Prophylaxis in Critically Ill Patients Resolving Discordant Meta-Analyses" @default.
- W2008616417 doi "https://doi.org/10.1097/00132586-199612000-00009" @default.
- W2008616417 hasPublicationYear "1996" @default.
- W2008616417 type Work @default.
- W2008616417 sameAs 2008616417 @default.
- W2008616417 citedByCount "0" @default.
- W2008616417 crossrefType "journal-article" @default.
- W2008616417 hasAuthorship W2008616417A5012951861 @default.
- W2008616417 hasAuthorship W2008616417A5015709785 @default.
- W2008616417 hasAuthorship W2008616417A5017849159 @default.
- W2008616417 hasAuthorship W2008616417A5025705076 @default.
- W2008616417 hasAuthorship W2008616417A5031717153 @default.
- W2008616417 hasAuthorship W2008616417A5082524174 @default.
- W2008616417 hasAuthorship W2008616417A5084752934 @default.
- W2008616417 hasConcept C120665830 @default.
- W2008616417 hasConcept C121332964 @default.
- W2008616417 hasConcept C126322002 @default.
- W2008616417 hasConcept C156957248 @default.
- W2008616417 hasConcept C168563851 @default.
- W2008616417 hasConcept C177713679 @default.
- W2008616417 hasConcept C2776246392 @default.
- W2008616417 hasConcept C2776672619 @default.
- W2008616417 hasConcept C2777914695 @default.
- W2008616417 hasConcept C2778080469 @default.
- W2008616417 hasConcept C2908647359 @default.
- W2008616417 hasConcept C44249647 @default.
- W2008616417 hasConcept C535046627 @default.
- W2008616417 hasConcept C61511704 @default.
- W2008616417 hasConcept C71924100 @default.
- W2008616417 hasConcept C95190672 @default.
- W2008616417 hasConcept C99454951 @default.
- W2008616417 hasConceptScore W2008616417C120665830 @default.
- W2008616417 hasConceptScore W2008616417C121332964 @default.
- W2008616417 hasConceptScore W2008616417C126322002 @default.
- W2008616417 hasConceptScore W2008616417C156957248 @default.
- W2008616417 hasConceptScore W2008616417C168563851 @default.
- W2008616417 hasConceptScore W2008616417C177713679 @default.
- W2008616417 hasConceptScore W2008616417C2776246392 @default.
- W2008616417 hasConceptScore W2008616417C2776672619 @default.
- W2008616417 hasConceptScore W2008616417C2777914695 @default.
- W2008616417 hasConceptScore W2008616417C2778080469 @default.
- W2008616417 hasConceptScore W2008616417C2908647359 @default.
- W2008616417 hasConceptScore W2008616417C44249647 @default.
- W2008616417 hasConceptScore W2008616417C535046627 @default.
- W2008616417 hasConceptScore W2008616417C61511704 @default.
- W2008616417 hasConceptScore W2008616417C71924100 @default.
- W2008616417 hasConceptScore W2008616417C95190672 @default.
- W2008616417 hasConceptScore W2008616417C99454951 @default.
- W2008616417 hasLocation W20086164171 @default.
- W2008616417 hasOpenAccess W2008616417 @default.
- W2008616417 hasPrimaryLocation W20086164171 @default.
- W2008616417 hasRelatedWork W108992697 @default.
- W2008616417 hasRelatedWork W1503156164 @default.
- W2008616417 hasRelatedWork W1598593590 @default.
- W2008616417 hasRelatedWork W1806512189 @default.
- W2008616417 hasRelatedWork W2040033828 @default.
- W2008616417 hasRelatedWork W2091105678 @default.
- W2008616417 hasRelatedWork W2117993778 @default.
- W2008616417 hasRelatedWork W2346892182 @default.
- W2008616417 hasRelatedWork W2594037077 @default.
- W2008616417 hasRelatedWork W2774163295 @default.
- W2008616417 hasRelatedWork W2886238511 @default.
- W2008616417 hasRelatedWork W2914771545 @default.
- W2008616417 hasRelatedWork W2990837298 @default.
- W2008616417 hasRelatedWork W2998172629 @default.
- W2008616417 hasRelatedWork W3004836515 @default.
- W2008616417 hasRelatedWork W3005771635 @default.
- W2008616417 hasRelatedWork W3084400443 @default.
- W2008616417 hasRelatedWork W3097509576 @default.
- W2008616417 hasRelatedWork W3158396996 @default.
- W2008616417 hasRelatedWork W3164159648 @default.
- W2008616417 isParatext "false" @default.
- W2008616417 isRetracted "false" @default.
- W2008616417 magId "2008616417" @default.
- W2008616417 workType "article" @default.